Fluidigm to Report Q1 2017 Financial Results and Host Conference Call
20 avr. 2017 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 20, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced it will report first quarter 2017 financial results on Thursday, May 4, 2017, after...
Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors
27 mars 2017 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Nicolas Barthelemy and Dr. Carlos Paya have been appointed to its Board of...
Fluidigm to Present at Cowen and Company 37th Annual Health Care Conference
23 févr. 2017 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, will present at the Cowen and Company 37th...
Fluidigm Announces Preliminary Revenue for the Fourth Quarter and Full Year Ended December 31, 2016
09 janv. 2017 16h15 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2016. ...
Fluidigm Introduces a New Medium-Cell High-Throughput Integrated Fluidic Circuit With Higher Single-Cell Capture Performance on the C1
21 déc. 2016 09h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announces the release of a new high-throughput integrated fluidic circuit (HT IFC) to...
Fluidigm to Present at Piper Jaffray 28th Annual Healthcare Conference
29 nov. 2016 13h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will webcast the company’s presentation at the Piper Jaffray 28th Annual...
Fluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels for Immuno-Oncology Research
10 nov. 2016 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of a modular set of high-parameter Maxpar® mass cytometry...
Fluidigm and GenomOncology Partner to Provide Automated Oncology NGS Library Preparation With Molecular Interpretation and Reporting
09 nov. 2016 08h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced a distribution agreement to co-market the GO Clinical Workbench™...
Fluidigm to Report Q3 2016 Financial Results and Host Conference Call
24 oct. 2016 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced it will report third quarter 2016 financial results on Thursday, November 3, 2016,...
Fluidigm Names S. Christopher Linthwaite as New Chief Executive Officer
19 oct. 2016 17h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that its Board of Directors has appointed S. Christopher Linthwaite as Chief...